Echo Street Capital Management’s West Pharmaceutical WST Stock Holding History

Echo Street Capital Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-885	Closed	-$332K	–	429
2023 Q3	$332K	Sell	885 -140	-14%	-$54.1K	﹤0.01%	350
2023 Q2	$392K	Buy	+1,025	New	+$366K	﹤0.01%	332
2022 Q4	–	Sell	-1,777	Closed	-$437K	–	669
2022 Q3	$437K	Buy	+1,777	New	+$541K	﹤0.01%	310
2021 Q4	–	Sell	-2,399	Closed	-$1.02M	–	762
2021 Q3	$1.02M	Sell	2,399 -998	-29%	-$421K	0.01%	239
2021 Q2	$1.22M	Buy	+3,397	New	+$1.12M	0.01%	177

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Echo Street Capital Management's WST Position: Q4 2023 in Review

Echo Street Capital Management sold out of West Pharmaceutical (WST) in Q4 2023, closing a stake of 885 shares — an estimated $332K sold.

Echo Street Capital Management first reported a position in WST in Q2 2021 and held it in 5 quarters. The position peaked at $1.22M in Q2 2021. 783 funds tracked by Wall St. Rank hold WST as of Q4 2023.

Echo Street Capital Management reported no remaining West Pharmaceutical position as of Q4 2023 after selling out during the quarter.
Echo Street Capital Management sold 885 West Pharmaceutical shares in Q4 2023, an estimated $332K.
Echo Street Capital Management first reported a position in West Pharmaceutical in Q2 2021 and held it in 5 quarters.
Echo Street Capital Management's West Pharmaceutical position peaked at $1.22M in Q2 2021.
783 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2023.

Based on Echo Street Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.